Prognostic significance of galectin ‐3 expression in patients with resected NSCLC treated with platinum‐based adjuvant chemotherapy

ConclusionsGAL3 expression is a reliable biomarker to predict the prognosis of completely resected NSCLC patients receiving platinum ‐based AC.

Source: Thoracic Cancer - April 1, 2021 Category: Cancer & Oncology Authors: Seiichiro Kusuhara, Satoshi Igawa, Masaaki Ichinoe, Ryo Nagashio, Yuki Kuchitsu, Yasuhiro Hiyoshi, Kazu Shiomi, Yoshiki Murakumo, Makoto Saegusa, Yukitoshi Satoh, Yuichi Sato, Katsuhiko Naoki Tags: ORIGINAL ARTICLE Source Type: research